Prescribing information

 

   

The COVID-19 pandemic has transformed dermatology services – but where do we go from here? Watch the webinar to get an expert view on how we can continue making positive changes for our patients.

Dr Laura Savage, a consultant dermatologist at Leeds Teaching Hospitals NHS Trust, discusses the impact of the pandemic on dermatology services, the opportunities and challenges of teledermatology, and how we can maintain positive transformation as normal services begin to resume.

“Many patients can be managed less frequently, they can be managed remotely or they can be managed with advice and guidance from the GP. That’s only going to continue to improve our capacity and reduces patient inconvenience.”

– Dr Laura Savage

 

 

Click here for Cosentyx (secukinumab) prescribing information

Want to know more about You First, our programme mentioned in the webinar, which provides support for Cosentyx patients at home? You First provides nurse-led support to any Cosentyx patient once the decision to prescribe Cosentyx has been made.  Find out more here.

CRP, C-reactive protein; DMARD, disease-modifying anti-rheumatic drug; MRI, magnetic resonance imaging; MTX, methotrexate.

COS20-C062 July 2020.
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events should also be reported to Novartis via [email protected] or online through the patient safety information (PSI) tool at https://psi.novartis.com
If you have a question about the product, please contact Medical Information on 01276 692255 or by email at [email protected]